STOCK TITAN

Domicilium Real Estate Fund III (NASDAQ: ELOX) reports large pre-funded warrant stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Domicilium Real Estate Fund III LP filed an initial ownership report for Eloxx Pharmaceuticals, Inc., disclosing indirect holdings in the company. The filing shows indirect ownership of 157,138 shares of common stock and a separate indirect position of 1,250,000 common shares.

The report also lists indirect holdings of Pre-Funded Warrants exercisable for 20,841,782 and 1,372,652 shares of common stock at an exercise price of $0.0100 per share. According to the disclosure, these Pre-Funded Warrants have no expiration date and are exercisable at any time, subject to a 4.99% beneficial ownership cap that limits exercises if they would push the holder above 4.99% of outstanding common stock.

Positive

  • None.

Negative

  • None.
Insider Domicilium Real Estate Fund III LP
Role null
Type Security Shares Price Value
holding Pre-funded Warrant -- -- --
holding Pre-funded Warrant -- -- --
holding Common Stock, $0.01 par value -- -- --
holding Common Stock, $0.01 par value -- -- --
Holdings After Transaction: Pre-funded Warrant — 1,372,652 shares (Indirect, See footnote); Common Stock, $0.01 par value — 1,250,000 shares (Indirect, See footnote)
Footnotes (1)
  1. The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium") the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner. The securities are owned by various entities and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to such entities and (ii) Daniel Simon, the managing member of Domicilium. The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Indirect common stock holding 1 157,138 shares Indirect ownership reported on Form 3
Indirect common stock holding 2 1,250,000 shares Additional indirect ownership line on Form 3
Pre-funded warrant block 1 20,841,782 underlying shares Indirect pre-funded warrants for Eloxx common stock
Pre-funded warrant block 2 1,372,652 underlying shares Additional indirect pre-funded warrants position
Warrant exercise price $0.0100 per share Exercise price of pre-funded warrants
Beneficial ownership cap 4.99% Maximum ownership allowed upon warrant exercise
Pre-Funded Warrants financial
"The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
beneficially own financial
"would beneficially own more than 4.99% of the number of shares of common stock outstanding"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
ten percent owner regulatory
""is_ten_percent_owner": 1"
indirectly beneficially owned financial
"may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC"
investment adviser financial
"Domicilium Capital Partners LLC, ("Domicilium") the investment adviser to the Fund"
An investment adviser is a person or firm that professionally manages money and gives recommendations about buying, selling, or holding investments. Like a financial coach or guide, they have a legal duty to act in a client's best financial interest, so their advice, fees and potential conflicts can directly affect returns and risk — making their role important for investors who want informed, accountable help with portfolios.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Domicilium Real Estate Fund III LP

(Last)(First)(Middle)
535 S. KIMBALL AVE, SUITE 140

(Street)
SOUTHLAKE TEXAS 76092

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/28/2026
3. Issuer Name and Ticker or Trading Symbol
Eloxx Pharmaceuticals, Inc. [ ELOX ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.01 par value1,250,000ISee footnote(1)
Common Stock, $0.01 par value157,138ISee footnote(2)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Pre-funded Warrant (3) (3)Common Stock, $0.01 par value1,372,652$0.01ISee footnote(1)
Pre-funded Warrant (3) (3)Common Stock, $0.01 par value20,841,782$0.01ISee footnote(2)
Explanation of Responses:
1. The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium") the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner.
2. The securities are owned by various entities and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to such entities and (ii) Daniel Simon, the managing member of Domicilium.
3. The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Remarks:
Domicilium Capital Partners LLC, Domicilium Real Estate Fund III GP LLC and Daniel Simon will be reported as a Reporting Person on a subsequent Form 3 once CIK codes are received.
Domicilium Real Estate Fund III LP, By: Domicilium Real Estate Fund III GP LLC, its General Partner, By: /s/ Daniel Simon, Managing Member05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What did Domicilium Real Estate Fund III LP report in its Form 3 for ELOX?

Domicilium Real Estate Fund III LP reported initial indirect ownership in Eloxx Pharmaceuticals. It disclosed 157,138 and 1,250,000 shares of common stock held indirectly, plus large positions in pre-funded warrants that can convert into additional common shares under specified conditions.

How many Eloxx (ELOX) common shares does Domicilium indirectly hold?

The filing shows Domicilium-linked entities indirectly hold 157,138 shares of Eloxx common stock in one line and 1,250,000 shares in another. These positions reflect existing equity exposure separate from any shares that could be obtained by exercising the pre-funded warrants.

What pre-funded warrant position did Domicilium report in Eloxx (ELOX)?

Domicilium-related entities reported indirect holdings of pre-funded warrants exercisable into 20,841,782 and 1,372,652 Eloxx common shares. These warrants carry a low exercise price of $0.0100 per share, providing significant potential equity exposure if exercised over time under the warrant terms.

Do the Eloxx (ELOX) pre-funded warrants held by Domicilium expire?

According to the disclosure, the pre-funded warrants have no expiration date and are exercisable at any time after issuance. This gives the holder long-term flexibility to convert into Eloxx common stock, subject to the stated beneficial ownership limitation in the warrant terms.

What is the 4.99% beneficial ownership cap mentioned in the Eloxx (ELOX) filing?

The filing states the pre-funded warrants cannot be exercised if it would cause the holder and its affiliates to beneficially own more than 4.99% of Eloxx’s outstanding common stock. This cap limits how many warrants can be exercised at once to control ownership concentration.

Who else may be deemed to beneficially own the Eloxx (ELOX) securities reported by Domicilium?

Footnotes indicate the securities may be deemed indirectly beneficially owned by Domicilium Capital Partners LLC, its affiliated general partner entities, and Daniel Simon as managing member. These parties are associated through advisory and control roles over the investment entities holding the securities.